PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Debilitating Disorders with Novel CBD-based Drug Delivery Platform

June 25, 2018 12:09:58
  • Direct health care treatment for chronic health conditions totaled $1.1 trillion in 2016
  • Total economic impact of $3.7 trillion in health care costs for chronic diseases in U.S. equivalent to nearly 20 percent of the U.S. gross domestic product
  • Medical research into CBD-based therapies to treat epilepsy and other neuropsychiatric disorders holds great promise for affected individuals
  • Development of CBD-based drug delivery platform that’s able to cross blood brain barrier via nasal route

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is developing innovative options for preventive and curative therapies using some of nature’s most compelling and creative pathways. Consider, for instance, PreveCeutical’s approach to delivering the healing properties of cannabidiol (“CBD”) in an innovative formula created specifically for administration via the nasal pathways. The company’s Sol-gel delivery platform is expected to be the first sustained-release, CBD-based nose-to-brain delivery system targeting a range of indications including epileptic seizures, inflammation, pain and other neurological disorders, an article discussing the research states (http://nnw.fm/6JA8f).

Chronic diseases and recurring health care issues are taking an increasingly bigger piece of the economic pie and disrupting the lives of many millions of people. U.S. health care costs for chronic diseases totaled $1.1 trillion in 2016 and balloon to…

Read More>>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com